BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)-Reference-Cited by-同舟云学术

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

Published:2021-12 Issue:6 Volume:5 Page:1012-1020
ISSN:2542-4548
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
language:en
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Author:

Slostad Jessica A.^ORCID,Liu Minetta C.,Allred Jacob B.,Erickson Lori A.,Rumilla Kandelaria M.,Block Matthew S.,Keppen Michael,King David,Markovic Svetomir N.^ORCID,McWilliams Robert R.

Funder

National Institutes of Health

National Cancer Institute

Genentech Inc

Novartis Pharmaceuticals Corp

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Recent advances in malignant melanoma;Atkinson;Intern Med J,2017

2. Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors;Sanmamed;Clin Chem,2015

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

5. BRAF mutation testing in cell-free DNA from the plasma of patients with advanced cancers using a rapid, automated molecular diagnostics system;Janku;Mol Cancer Ther,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1;Frontiers in Oncology;2023-08-17

2. Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors;The Journal of Molecular Diagnostics;2023-07

3. Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: a prospective cohort study;Therapeutic Advances in Medical Oncology;2022-01

4. Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-12-07